Indivior Pharmaceuticals, Inc. Common Stock (INDV) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for INDV. 13F holdings as of 2026-06-30.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| BlackRock | 18,709,432 | $768M | INCREASED |
| Vanguard | 14,125,841 | $580M | DECREASED |
| Oaktree Capital Management | 6,127,212 | $251M | DECREASED |
| State Street | 4,992,071 | $205M | INCREASED |
| Fuller & Thaler Asset Management | 4,615,816 | $189M | INCREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Woodrow D Anderson (Chief Accounting Officer) | BUY | 1,500 | $54K | 2026-08-27 |
| Woodrow D Anderson (Chief Accounting Officer) | BUY | 1,500 | $54K | 2026-08-05 |
| Christian Heidbreder (Chief Scientific Officer) | SELL | 18,586 | $765K | 2026-07-10 |
Full institutional holdings, insider history, and congressional trades for Indivior Pharmaceuticals, Inc. Common Stock on SentiSense.